GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxj3
|
ENSMUSG00000032998.17 | forkhead box J3 |
Tbl1xr1
|
ENSMUSG00000027630.14 | transducin (beta)-like 1X-linked receptor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxj3 | mm39_v1_chr4_+_119396849_119396912 | 0.62 | 5.5e-05 | Click! |
Tbl1xr1 | mm39_v1_chr3_+_22130866_22130961 | 0.41 | 1.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_79722081 | 20.90 |
ENSMUST00000046091.7
|
Elane
|
elastase, neutrophil expressed |
chr16_-_36228798 | 16.84 |
ENSMUST00000023619.8
|
Stfa2
|
stefin A2 |
chr16_+_36004452 | 14.24 |
ENSMUST00000114858.2
|
Cstdc4
|
cystatin domain containing 4 |
chr7_+_13467422 | 13.63 |
ENSMUST00000086148.8
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr3_-_90603013 | 13.42 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr5_+_90638580 | 12.84 |
ENSMUST00000042755.7
ENSMUST00000200693.2 |
Afp
|
alpha fetoprotein |
chr7_-_13571334 | 11.75 |
ENSMUST00000108522.5
|
Sult2a1
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
chr1_+_174000304 | 11.05 |
ENSMUST00000027817.8
|
Spta1
|
spectrin alpha, erythrocytic 1 |
chr10_-_111833138 | 10.24 |
ENSMUST00000074805.12
|
Glipr1
|
GLI pathogenesis-related 1 (glioma) |
chr11_-_55075855 | 9.35 |
ENSMUST00000039305.6
|
Slc36a2
|
solute carrier family 36 (proton/amino acid symporter), member 2 |
chrX_+_8137620 | 9.28 |
ENSMUST00000033512.11
|
Slc38a5
|
solute carrier family 38, member 5 |
chr6_-_41681273 | 9.05 |
ENSMUST00000031899.14
|
Kel
|
Kell blood group |
chr4_+_134591847 | 8.96 |
ENSMUST00000030627.8
|
Rhd
|
Rh blood group, D antigen |
chrX_+_8137372 | 8.49 |
ENSMUST00000127103.8
ENSMUST00000115591.8 |
Slc38a5
|
solute carrier family 38, member 5 |
chr19_-_20368029 | 8.45 |
ENSMUST00000235280.2
|
Anxa1
|
annexin A1 |
chr7_-_103463120 | 8.04 |
ENSMUST00000098192.4
|
Hbb-bt
|
hemoglobin, beta adult t chain |
chr7_-_100164007 | 7.78 |
ENSMUST00000207405.2
|
Dnajb13
|
DnaJ heat shock protein family (Hsp40) member B13 |
chr14_-_56339915 | 7.58 |
ENSMUST00000015583.2
|
Ctsg
|
cathepsin G |
chr2_-_32278245 | 7.42 |
ENSMUST00000192241.2
|
Lcn2
|
lipocalin 2 |
chr17_+_41121979 | 7.40 |
ENSMUST00000024721.8
ENSMUST00000233740.2 |
Rhag
|
Rhesus blood group-associated A glycoprotein |
chr17_+_37180437 | 7.37 |
ENSMUST00000060524.11
|
Trim10
|
tripartite motif-containing 10 |
chr3_-_98247237 | 7.32 |
ENSMUST00000065793.12
|
Phgdh
|
3-phosphoglycerate dehydrogenase |
chr16_-_36188086 | 7.24 |
ENSMUST00000096089.3
|
Cstdc5
|
cystatin domain containing 5 |
chr1_-_45542442 | 7.02 |
ENSMUST00000086430.5
|
Col5a2
|
collagen, type V, alpha 2 |
chr6_+_34389269 | 7.01 |
ENSMUST00000007449.9
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr7_-_103477126 | 6.84 |
ENSMUST00000023934.8
|
Hbb-bs
|
hemoglobin, beta adult s chain |
chr11_+_32236945 | 6.66 |
ENSMUST00000101387.4
|
Hbq1b
|
hemoglobin, theta 1B |
chr3_+_51568588 | 6.63 |
ENSMUST00000099106.10
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr16_+_35977170 | 6.54 |
ENSMUST00000079184.6
|
Stfa2l1
|
stefin A2 like 1 |
chr9_+_110848339 | 6.51 |
ENSMUST00000198884.5
ENSMUST00000196777.5 ENSMUST00000196209.5 ENSMUST00000035077.8 ENSMUST00000196122.3 |
Ltf
|
lactotransferrin |
chr16_+_48692976 | 6.38 |
ENSMUST00000065666.6
|
Retnlg
|
resistin like gamma |
chr2_-_28511941 | 6.25 |
ENSMUST00000028156.8
ENSMUST00000164290.8 |
Gfi1b
|
growth factor independent 1B |
chr4_-_119047202 | 6.06 |
ENSMUST00000239029.2
ENSMUST00000138395.9 ENSMUST00000156746.3 |
Ermap
|
erythroblast membrane-associated protein |
chr11_+_32233511 | 5.97 |
ENSMUST00000093209.4
|
Hba-a1
|
hemoglobin alpha, adult chain 1 |
chr5_+_149201577 | 5.97 |
ENSMUST00000071130.5
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein |
chr3_+_51568625 | 5.93 |
ENSMUST00000159554.7
ENSMUST00000161590.4 |
Mgst2
|
microsomal glutathione S-transferase 2 |
chr6_-_115739284 | 5.92 |
ENSMUST00000166254.7
ENSMUST00000170625.8 |
Tmem40
|
transmembrane protein 40 |
chr9_+_115738523 | 5.86 |
ENSMUST00000119291.8
ENSMUST00000069651.13 |
Gadl1
|
glutamate decarboxylase-like 1 |
chr10_+_115653152 | 5.79 |
ENSMUST00000080630.11
ENSMUST00000179196.3 ENSMUST00000035563.15 |
Tspan8
|
tetraspanin 8 |
chr11_-_83177548 | 5.75 |
ENSMUST00000163961.3
|
Slfn14
|
schlafen 14 |
chr7_+_100142977 | 5.69 |
ENSMUST00000129324.8
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_-_120867529 | 5.67 |
ENSMUST00000102490.10
|
Epb42
|
erythrocyte membrane protein band 4.2 |
chr16_+_38182569 | 5.65 |
ENSMUST00000023494.13
ENSMUST00000114739.2 |
Popdc2
|
popeye domain containing 2 |
chr8_+_23525101 | 5.51 |
ENSMUST00000117662.8
ENSMUST00000117296.8 ENSMUST00000141784.9 |
Ank1
|
ankyrin 1, erythroid |
chrX_+_8137881 | 5.51 |
ENSMUST00000115590.2
|
Slc38a5
|
solute carrier family 38, member 5 |
chr11_-_69508706 | 5.37 |
ENSMUST00000005334.3
|
Shbg
|
sex hormone binding globulin |
chr11_-_6470918 | 5.31 |
ENSMUST00000003459.4
|
Myo1g
|
myosin IG |
chr4_+_123176570 | 5.18 |
ENSMUST00000106243.8
ENSMUST00000106241.8 ENSMUST00000080178.13 |
Pabpc4
|
poly(A) binding protein, cytoplasmic 4 |
chr4_-_155013002 | 5.14 |
ENSMUST00000152687.8
ENSMUST00000137803.8 ENSMUST00000145296.2 |
Tnfrsf14
|
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
chr16_+_36073416 | 5.14 |
ENSMUST00000063539.7
|
Csta2
|
cystatin A family member 2 |
chr11_-_102360664 | 5.11 |
ENSMUST00000103086.4
|
Itga2b
|
integrin alpha 2b |
chr7_+_13357892 | 5.06 |
ENSMUST00000108525.4
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr4_-_119047167 | 5.06 |
ENSMUST00000030396.15
|
Ermap
|
erythroblast membrane-associated protein |
chr1_-_132318039 | 5.04 |
ENSMUST00000132435.2
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr16_+_36097505 | 5.03 |
ENSMUST00000042097.11
|
Stfa1
|
stefin A1 |
chrX_+_149330371 | 5.02 |
ENSMUST00000066337.13
ENSMUST00000112715.2 |
Alas2
|
aminolevulinic acid synthase 2, erythroid |
chrX_+_92698469 | 4.96 |
ENSMUST00000113933.9
|
Pcyt1b
|
phosphate cytidylyltransferase 1, choline, beta isoform |
chr5_+_90920353 | 4.93 |
ENSMUST00000202625.2
|
Pf4
|
platelet factor 4 |
chr1_-_133681419 | 4.91 |
ENSMUST00000125659.8
ENSMUST00000048953.14 ENSMUST00000165602.9 |
Atp2b4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr4_+_44300876 | 4.89 |
ENSMUST00000045607.12
|
Melk
|
maternal embryonic leucine zipper kinase |
chr16_+_36041838 | 4.88 |
ENSMUST00000187183.7
ENSMUST00000187742.7 |
Csta2
|
cystatin A family member 2 |
chr3_-_115923098 | 4.86 |
ENSMUST00000196449.5
|
Vcam1
|
vascular cell adhesion molecule 1 |
chr1_+_156193607 | 4.79 |
ENSMUST00000102782.4
|
Gm2000
|
predicted gene 2000 |
chr19_-_11618192 | 4.76 |
ENSMUST00000112984.4
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr13_-_4200627 | 4.69 |
ENSMUST00000110704.9
ENSMUST00000021635.9 |
Akr1c18
|
aldo-keto reductase family 1, member C18 |
chr19_-_11618165 | 4.68 |
ENSMUST00000186023.7
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr7_-_142220553 | 4.67 |
ENSMUST00000105935.8
|
Igf2
|
insulin-like growth factor 2 |
chr14_+_80237691 | 4.64 |
ENSMUST00000228749.2
ENSMUST00000088735.4 |
Olfm4
|
olfactomedin 4 |
chr6_+_30723540 | 4.63 |
ENSMUST00000141130.2
ENSMUST00000115127.8 |
Mest
|
mesoderm specific transcript |
chr3_-_106126794 | 4.55 |
ENSMUST00000082219.6
|
Chil4
|
chitinase-like 4 |
chr9_+_7558449 | 4.53 |
ENSMUST00000018765.4
|
Mmp8
|
matrix metallopeptidase 8 |
chr5_-_145406533 | 4.51 |
ENSMUST00000031633.5
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr5_-_114961501 | 4.48 |
ENSMUST00000100850.6
|
1500011B03Rik
|
RIKEN cDNA 1500011B03 gene |
chr7_+_100142544 | 4.46 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr4_-_46404224 | 4.43 |
ENSMUST00000107764.9
|
Hemgn
|
hemogen |
chr16_+_36097313 | 4.42 |
ENSMUST00000232150.2
|
Stfa1
|
stefin A1 |
chr2_+_174292471 | 4.40 |
ENSMUST00000016399.6
|
Tubb1
|
tubulin, beta 1 class VI |
chr6_+_129374441 | 4.38 |
ENSMUST00000112081.9
ENSMUST00000112079.3 |
Clec1b
|
C-type lectin domain family 1, member b |
chr4_-_132260799 | 4.37 |
ENSMUST00000152993.8
ENSMUST00000067496.7 |
Atpif1
|
ATPase inhibitory factor 1 |
chr18_-_67682312 | 4.36 |
ENSMUST00000224799.2
|
Spire1
|
spire type actin nucleation factor 1 |
chr10_+_20223516 | 4.31 |
ENSMUST00000169712.3
ENSMUST00000217608.2 |
Mtfr2
|
mitochondrial fission regulator 2 |
chr1_+_163889551 | 4.31 |
ENSMUST00000192047.6
ENSMUST00000027871.13 |
Sell
|
selectin, lymphocyte |
chr5_+_149202157 | 4.28 |
ENSMUST00000200806.4
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein |
chr4_+_140737955 | 4.23 |
ENSMUST00000071977.9
|
Mfap2
|
microfibrillar-associated protein 2 |
chr18_-_60635059 | 4.19 |
ENSMUST00000042710.8
|
Smim3
|
small integral membrane protein 3 |
chr1_+_136395673 | 4.18 |
ENSMUST00000189413.7
ENSMUST00000047817.12 |
Kif14
|
kinesin family member 14 |
chr7_-_103492361 | 4.15 |
ENSMUST00000063957.6
|
Hbb-bh1
|
hemoglobin Z, beta-like embryonic chain |
chr10_+_79715448 | 4.15 |
ENSMUST00000006679.15
|
Prtn3
|
proteinase 3 |
chr13_-_49806231 | 4.15 |
ENSMUST00000021818.9
|
Cenpp
|
centromere protein P |
chr3_-_137687284 | 4.14 |
ENSMUST00000136613.4
ENSMUST00000029806.13 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr3_-_98767090 | 4.13 |
ENSMUST00000107016.10
ENSMUST00000029465.10 |
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chr10_-_88520877 | 4.05 |
ENSMUST00000138734.2
|
Spic
|
Spi-C transcription factor (Spi-1/PU.1 related) |
chr16_-_36275739 | 4.04 |
ENSMUST00000068182.3
|
Stfa3
|
stefin A3 |
chr3_-_113325938 | 4.01 |
ENSMUST00000132353.2
|
Amy2a1
|
amylase 2a1 |
chr8_-_73059104 | 3.99 |
ENSMUST00000075602.8
|
Gm10282
|
predicted pseudogene 10282 |
chr15_+_102204691 | 3.97 |
ENSMUST00000064924.6
ENSMUST00000230212.2 ENSMUST00000229050.2 ENSMUST00000231104.2 |
Espl1
|
extra spindle pole bodies 1, separase |
chr4_-_44710408 | 3.97 |
ENSMUST00000134968.9
ENSMUST00000173821.8 ENSMUST00000174319.8 ENSMUST00000173733.8 ENSMUST00000172866.8 ENSMUST00000165417.9 ENSMUST00000107825.9 ENSMUST00000102932.10 ENSMUST00000107827.9 ENSMUST00000107826.9 ENSMUST00000014174.14 |
Pax5
|
paired box 5 |
chrX_-_161747552 | 3.95 |
ENSMUST00000038769.3
|
S100g
|
S100 calcium binding protein G |
chr11_+_87685032 | 3.95 |
ENSMUST00000121303.8
|
Mpo
|
myeloperoxidase |
chrX_-_133483849 | 3.93 |
ENSMUST00000113213.2
ENSMUST00000033617.13 |
Btk
|
Bruton agammaglobulinemia tyrosine kinase |
chr1_-_149798090 | 3.87 |
ENSMUST00000111926.9
|
Pla2g4a
|
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr12_-_75678092 | 3.85 |
ENSMUST00000238938.2
|
Rplp2-ps1
|
ribosomal protein, large P2, pseudogene 1 |
chr11_-_115918784 | 3.82 |
ENSMUST00000106454.8
|
H3f3b
|
H3.3 histone B |
chrX_-_135116192 | 3.80 |
ENSMUST00000113120.2
ENSMUST00000113118.2 ENSMUST00000058125.9 |
Bex1
|
brain expressed X-linked 1 |
chr11_+_32246489 | 3.77 |
ENSMUST00000093207.4
|
Hba-a2
|
hemoglobin alpha, adult chain 2 |
chr11_-_99328969 | 3.76 |
ENSMUST00000017743.3
|
Krt20
|
keratin 20 |
chr6_+_41498716 | 3.75 |
ENSMUST00000070380.5
|
Prss2
|
protease, serine 2 |
chr3_-_113166153 | 3.73 |
ENSMUST00000098673.5
|
Amy2a5
|
amylase 2a5 |
chr6_+_124807176 | 3.73 |
ENSMUST00000131847.8
ENSMUST00000151674.3 |
Cdca3
|
cell division cycle associated 3 |
chrX_-_8011952 | 3.73 |
ENSMUST00000115615.9
ENSMUST00000115616.8 ENSMUST00000115621.9 |
Rbm3
|
RNA binding motif (RNP1, RRM) protein 3 |
chr3_+_90576285 | 3.71 |
ENSMUST00000069927.10
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr1_+_131566044 | 3.68 |
ENSMUST00000073350.13
|
Ctse
|
cathepsin E |
chr1_+_131566223 | 3.67 |
ENSMUST00000112411.2
|
Ctse
|
cathepsin E |
chr15_-_103159892 | 3.67 |
ENSMUST00000133600.8
ENSMUST00000134554.2 ENSMUST00000156927.8 |
Nfe2
|
nuclear factor, erythroid derived 2 |
chr2_-_70655997 | 3.66 |
ENSMUST00000038584.9
|
Tlk1
|
tousled-like kinase 1 |
chr2_+_119449192 | 3.65 |
ENSMUST00000028771.8
|
Nusap1
|
nucleolar and spindle associated protein 1 |
chr9_+_110867807 | 3.64 |
ENSMUST00000197575.2
|
Ltf
|
lactotransferrin |
chr1_+_51328265 | 3.62 |
ENSMUST00000051572.8
|
Cavin2
|
caveolae associated 2 |
chr3_-_151871867 | 3.60 |
ENSMUST00000046614.10
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr2_-_165242307 | 3.60 |
ENSMUST00000029213.5
|
Ocstamp
|
osteoclast stimulatory transmembrane protein |
chr11_-_11920540 | 3.59 |
ENSMUST00000109653.8
|
Grb10
|
growth factor receptor bound protein 10 |
chr11_-_98915005 | 3.59 |
ENSMUST00000068031.8
|
Top2a
|
topoisomerase (DNA) II alpha |
chr15_+_79776597 | 3.58 |
ENSMUST00000175714.8
ENSMUST00000109620.10 ENSMUST00000165537.8 ENSMUST00000175752.8 ENSMUST00000176325.8 |
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr9_+_98372575 | 3.58 |
ENSMUST00000035029.3
|
Rbp2
|
retinol binding protein 2, cellular |
chr7_-_103502404 | 3.55 |
ENSMUST00000033229.5
|
Hbb-y
|
hemoglobin Y, beta-like embryonic chain |
chr1_+_107456731 | 3.49 |
ENSMUST00000182198.8
|
Serpinb10
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10 |
chr11_+_72851989 | 3.49 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr10_+_129219952 | 3.44 |
ENSMUST00000214064.2
|
Olfr784
|
olfactory receptor 784 |
chr2_+_103799873 | 3.44 |
ENSMUST00000123437.8
|
Lmo2
|
LIM domain only 2 |
chr10_+_3923086 | 3.43 |
ENSMUST00000117291.8
ENSMUST00000120585.8 ENSMUST00000043735.8 |
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr15_+_79779218 | 3.42 |
ENSMUST00000023054.14
|
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr7_-_140597837 | 3.41 |
ENSMUST00000209328.2
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr9_-_21874802 | 3.41 |
ENSMUST00000006397.7
|
Epor
|
erythropoietin receptor |
chr6_-_7692855 | 3.39 |
ENSMUST00000115542.8
ENSMUST00000148349.2 |
Asns
|
asparagine synthetase |
chr1_-_173161069 | 3.37 |
ENSMUST00000038227.6
|
Ackr1
|
atypical chemokine receptor 1 (Duffy blood group) |
chr6_+_41279199 | 3.37 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr6_-_49191891 | 3.37 |
ENSMUST00000031838.9
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr19_-_5776268 | 3.35 |
ENSMUST00000075606.6
ENSMUST00000236215.2 ENSMUST00000235730.2 ENSMUST00000237081.2 ENSMUST00000049295.15 |
Ehbp1l1
|
EH domain binding protein 1-like 1 |
chr4_-_87724533 | 3.34 |
ENSMUST00000126353.8
ENSMUST00000149357.8 |
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
chrX_+_135145813 | 3.32 |
ENSMUST00000048687.11
|
Tceal9
|
transcription elongation factor A like 9 |
chr8_-_86091970 | 3.31 |
ENSMUST00000121972.8
|
Mylk3
|
myosin light chain kinase 3 |
chr1_-_153425791 | 3.31 |
ENSMUST00000041874.9
|
Npl
|
N-acetylneuraminate pyruvate lyase |
chr8_+_13389656 | 3.31 |
ENSMUST00000210165.2
ENSMUST00000170909.2 |
Tfdp1
|
transcription factor Dp 1 |
chr6_-_125168453 | 3.30 |
ENSMUST00000189959.2
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr7_+_100143250 | 3.30 |
ENSMUST00000153287.8
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr5_+_110478558 | 3.29 |
ENSMUST00000112481.2
|
Pole
|
polymerase (DNA directed), epsilon |
chr5_-_134258435 | 3.27 |
ENSMUST00000016094.13
ENSMUST00000111275.8 ENSMUST00000144086.2 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr1_+_173248104 | 3.27 |
ENSMUST00000173023.2
|
Aim2
|
absent in melanoma 2 |
chr1_+_163889713 | 3.25 |
ENSMUST00000097491.10
|
Sell
|
selectin, lymphocyte |
chr7_+_142014546 | 3.24 |
ENSMUST00000105968.8
ENSMUST00000018963.11 ENSMUST00000105967.8 |
Lsp1
|
lymphocyte specific 1 |
chr7_+_44221791 | 3.24 |
ENSMUST00000002274.10
|
Napsa
|
napsin A aspartic peptidase |
chr3_-_102074246 | 3.24 |
ENSMUST00000161021.2
|
Vangl1
|
VANGL planar cell polarity 1 |
chr8_-_86091946 | 3.23 |
ENSMUST00000034133.14
|
Mylk3
|
myosin light chain kinase 3 |
chr11_+_32250069 | 3.23 |
ENSMUST00000020535.2
|
Hbq1a
|
hemoglobin, theta 1A |
chr19_+_6135013 | 3.22 |
ENSMUST00000025704.3
|
Cdca5
|
cell division cycle associated 5 |
chr18_-_43870622 | 3.22 |
ENSMUST00000025381.4
|
Spink1
|
serine peptidase inhibitor, Kazal type 1 |
chr2_+_164611812 | 3.22 |
ENSMUST00000088248.13
ENSMUST00000001439.7 |
Ube2c
|
ubiquitin-conjugating enzyme E2C |
chr11_+_70529944 | 3.22 |
ENSMUST00000055184.7
ENSMUST00000108551.3 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr7_-_142211203 | 3.21 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
Igf2
|
insulin-like growth factor 2 |
chr14_-_79539063 | 3.21 |
ENSMUST00000022595.8
|
Rgcc
|
regulator of cell cycle |
chr17_+_43878989 | 3.18 |
ENSMUST00000167214.8
ENSMUST00000024706.12 |
Pla2g7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chrX_-_7537580 | 3.18 |
ENSMUST00000033486.6
|
Plp2
|
proteolipid protein 2 |
chr2_+_121337226 | 3.16 |
ENSMUST00000099473.10
ENSMUST00000110602.9 |
Wdr76
|
WD repeat domain 76 |
chr2_+_103800553 | 3.12 |
ENSMUST00000111140.3
ENSMUST00000111139.3 |
Lmo2
|
LIM domain only 2 |
chr6_+_123206802 | 3.11 |
ENSMUST00000112554.9
ENSMUST00000024118.11 ENSMUST00000117130.8 |
Clec4n
|
C-type lectin domain family 4, member n |
chr9_+_20940669 | 3.10 |
ENSMUST00000001040.7
ENSMUST00000215077.2 |
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr13_-_19803928 | 3.09 |
ENSMUST00000221014.2
ENSMUST00000002885.8 ENSMUST00000220944.2 |
Epdr1
|
ependymin related protein 1 (zebrafish) |
chr13_-_97897139 | 3.09 |
ENSMUST00000074072.5
|
Rps18-ps6
|
ribosomal protein S18, pseudogene 6 |
chr1_-_131066004 | 3.09 |
ENSMUST00000016670.9
|
Dyrk3
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
chr18_-_32044877 | 3.08 |
ENSMUST00000054984.8
|
Sft2d3
|
SFT2 domain containing 3 |
chr4_-_87724512 | 3.06 |
ENSMUST00000148059.2
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
chr4_+_114914880 | 3.06 |
ENSMUST00000161601.8
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr1_-_169358912 | 3.06 |
ENSMUST00000192248.2
ENSMUST00000028000.13 |
Nuf2
|
NUF2, NDC80 kinetochore complex component |
chr9_+_109704609 | 3.06 |
ENSMUST00000094324.8
|
Cdc25a
|
cell division cycle 25A |
chr6_-_41291634 | 3.05 |
ENSMUST00000064324.12
|
Try5
|
trypsin 5 |
chr11_-_69496655 | 3.04 |
ENSMUST00000047889.13
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr7_-_24459736 | 3.02 |
ENSMUST00000063956.7
|
Cd177
|
CD177 antigen |
chr7_+_24561616 | 3.02 |
ENSMUST00000170837.3
|
Gm9844
|
predicted pseudogene 9844 |
chr17_-_48758538 | 3.02 |
ENSMUST00000024794.12
|
Tspo2
|
translocator protein 2 |
chr10_+_75778885 | 2.99 |
ENSMUST00000121151.2
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr14_+_30930266 | 2.99 |
ENSMUST00000169169.8
|
Tnnc1
|
troponin C, cardiac/slow skeletal |
chr7_-_140596811 | 2.97 |
ENSMUST00000081924.5
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr18_+_34758062 | 2.97 |
ENSMUST00000166044.3
|
Kif20a
|
kinesin family member 20A |
chr2_+_84818538 | 2.97 |
ENSMUST00000028466.12
|
Prg3
|
proteoglycan 3 |
chr8_-_54091980 | 2.95 |
ENSMUST00000047768.11
|
Neil3
|
nei like 3 (E. coli) |
chr8_+_75820240 | 2.94 |
ENSMUST00000005548.8
|
Hmox1
|
heme oxygenase 1 |
chr5_+_30824121 | 2.93 |
ENSMUST00000144742.6
ENSMUST00000149759.2 ENSMUST00000199320.5 |
Cenpa
|
centromere protein A |
chr6_+_121613177 | 2.93 |
ENSMUST00000032203.9
|
A2m
|
alpha-2-macroglobulin |
chr8_+_81220410 | 2.92 |
ENSMUST00000063359.8
|
Gypa
|
glycophorin A |
chr4_-_117039809 | 2.92 |
ENSMUST00000065896.9
|
Kif2c
|
kinesin family member 2C |
chr1_-_167221344 | 2.91 |
ENSMUST00000028005.3
|
Mgst3
|
microsomal glutathione S-transferase 3 |
chr5_-_100710702 | 2.90 |
ENSMUST00000097437.9
|
Plac8
|
placenta-specific 8 |
chr1_+_172327569 | 2.89 |
ENSMUST00000111230.8
|
Tagln2
|
transgelin 2 |
chr5_-_138169253 | 2.89 |
ENSMUST00000139983.8
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr15_-_91075933 | 2.86 |
ENSMUST00000069511.8
|
Abcd2
|
ATP-binding cassette, sub-family D (ALD), member 2 |
chr2_+_84564394 | 2.86 |
ENSMUST00000238573.2
ENSMUST00000090729.9 |
Ypel4
|
yippee like 4 |
chr8_+_57964921 | 2.85 |
ENSMUST00000067925.8
|
Hmgb2
|
high mobility group box 2 |
chr17_+_47816074 | 2.83 |
ENSMUST00000183177.8
ENSMUST00000182848.8 |
Ccnd3
|
cyclin D3 |
chrX_-_132799144 | 2.82 |
ENSMUST00000087557.12
|
Tspan6
|
tetraspanin 6 |
chr1_-_144651157 | 2.80 |
ENSMUST00000027603.4
|
Rgs18
|
regulator of G-protein signaling 18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 23.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
4.4 | 13.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.1 | 16.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
3.3 | 10.0 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.7 | 8.0 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
2.6 | 10.5 | GO:0036233 | glycine import(GO:0036233) |
2.5 | 10.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
2.4 | 9.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.3 | 13.5 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.1 | 8.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
2.1 | 10.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
2.1 | 4.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.9 | 7.7 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.9 | 11.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.7 | 6.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 1.7 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.7 | 23.2 | GO:0015816 | glycine transport(GO:0015816) |
1.6 | 4.7 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.6 | 4.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.5 | 4.6 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.5 | 4.5 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
1.5 | 3.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.5 | 9.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.5 | 4.4 | GO:0010925 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
1.5 | 7.3 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.4 | 4.2 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
1.4 | 8.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
1.4 | 4.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.4 | 4.1 | GO:0021693 | cerebellar Purkinje cell layer structural organization(GO:0021693) |
1.4 | 13.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.4 | 6.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.3 | 5.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.3 | 2.6 | GO:0006272 | leading strand elongation(GO:0006272) |
1.3 | 2.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.3 | 5.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.3 | 10.5 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
1.3 | 6.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.3 | 6.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 3.7 | GO:0002215 | defense response to nematode(GO:0002215) |
1.2 | 1.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.2 | 3.6 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
1.2 | 8.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.1 | 6.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.1 | 14.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 3.3 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.1 | 5.5 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.1 | 1.1 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
1.1 | 9.7 | GO:0015671 | oxygen transport(GO:0015671) |
1.1 | 7.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.1 | 1.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.0 | 2.1 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.0 | 4.1 | GO:0045575 | basophil activation(GO:0045575) |
1.0 | 6.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.0 | 17.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.0 | 5.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.0 | 2.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.0 | 2.9 | GO:0006788 | heme oxidation(GO:0006788) |
1.0 | 4.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.9 | 5.7 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.9 | 2.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.9 | 2.8 | GO:0071846 | actin filament debranching(GO:0071846) |
0.9 | 2.7 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.9 | 3.6 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.9 | 1.8 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.9 | 7.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.9 | 2.6 | GO:0030221 | basophil differentiation(GO:0030221) |
0.9 | 6.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.9 | 16.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 11.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.8 | 5.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 5.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.8 | 4.2 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.8 | 2.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.8 | 3.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.8 | 7.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 1.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.8 | 3.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.8 | 3.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.8 | 4.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.8 | 2.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.8 | 4.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 3.9 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.8 | 2.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.8 | 3.1 | GO:0033368 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.8 | 0.8 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.8 | 1.6 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.8 | 3.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.8 | 3.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.8 | 2.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.8 | 35.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.8 | 4.6 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.8 | 0.8 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.7 | 3.0 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.7 | 2.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.7 | 2.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
0.7 | 2.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 2.9 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.7 | 2.9 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.7 | 2.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 0.7 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.7 | 2.9 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.7 | 1.4 | GO:0009644 | response to high light intensity(GO:0009644) |
0.7 | 21.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.7 | 8.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.7 | 2.8 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.7 | 2.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 2.0 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.7 | 2.0 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 0.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.7 | 2.0 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.7 | 2.0 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.6 | 1.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 1.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 3.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 0.6 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.6 | 1.3 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.6 | 7.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 8.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.6 | 3.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.6 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 1.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 1.9 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.6 | 1.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.6 | 10.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 0.6 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 1.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 | 6.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 2.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.6 | 3.0 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.6 | 1.8 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.6 | 1.2 | GO:0031179 | peptide modification(GO:0031179) |
0.6 | 1.8 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.6 | 2.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.6 | 2.3 | GO:0046722 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.6 | 4.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 4.6 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.6 | 3.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.6 | 2.3 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.6 | 1.7 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.6 | 11.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 2.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 2.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 11.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 2.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.6 | 1.7 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
0.6 | 1.7 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.5 | 9.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 2.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.5 | 1.1 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.5 | 2.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 10.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 1.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 3.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.5 | 5.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.5 | 1.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 1.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 1.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 1.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 4.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 5.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.5 | 4.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 3.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.5 | 0.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.5 | 1.0 | GO:0033189 | response to vitamin A(GO:0033189) |
0.5 | 4.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 4.0 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 3.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.5 | 2.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 13.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.5 | 0.5 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.5 | 8.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 1.5 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.5 | 0.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.5 | 6.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 3.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 1.9 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
0.5 | 1.0 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.5 | 1.5 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.5 | 1.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 6.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 3.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 6.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.5 | 2.9 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.5 | 0.5 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.5 | 1.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 1.4 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.5 | 3.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.4 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
0.5 | 0.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.5 | 2.4 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.5 | 3.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 1.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.5 | 3.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 | 9.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 9.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 2.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 5.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 3.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 1.4 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.5 | 1.4 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.5 | 0.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.4 | 3.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 8.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 0.9 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 1.8 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 11.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 3.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 1.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 3.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 1.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.4 | 4.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 2.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 3.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 4.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 3.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.3 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 0.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.4 | 1.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.4 | 2.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 2.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 1.7 | GO:0030421 | defecation(GO:0030421) |
0.4 | 2.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 2.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 8.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.4 | 2.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 1.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.4 | 1.6 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.4 | 1.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 3.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 4.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 1.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.4 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 1.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 3.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.4 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.4 | 8.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.4 | 4.4 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.4 | 1.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 1.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 2.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 4.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 1.5 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.4 | 3.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 0.4 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.4 | 0.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 3.8 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 1.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 5.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 2.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.4 | 1.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.4 | 0.8 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 5.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 1.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 1.1 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
0.4 | 1.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 1.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 2.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 8.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 0.7 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 1.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.4 | 1.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 2.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.4 | 1.8 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 2.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 2.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 3.1 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.3 | 2.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 2.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.0 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 10.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 5.5 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 7.2 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.3 | 1.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.7 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.3 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 2.9 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 4.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 2.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 11.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 2.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.3 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.3 | 4.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 2.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 5.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.9 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 1.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.3 | 2.5 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.3 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.9 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 | 2.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 13.1 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 1.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 1.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.3 | 0.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.3 | 2.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 1.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 0.3 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.3 | 0.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 1.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 0.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.3 | 2.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.3 | 0.6 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 1.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 2.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 0.9 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.3 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 0.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.3 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.9 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.3 | 5.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 0.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.3 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 2.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 2.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 5.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.3 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 3.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 2.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 6.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 2.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 1.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.4 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.3 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 0.8 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.3 | 3.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 2.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.3 | 1.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.3 | 1.1 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.3 | 5.7 | GO:0010458 | exit from mitosis(GO:0010458) |
0.3 | 2.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.3 | 1.1 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 1.3 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.8 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
0.3 | 1.6 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 4.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 15.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 1.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.8 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.3 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 17.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 0.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 1.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.3 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 6.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 5.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 1.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 2.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 3.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 4.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.8 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.3 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 4.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 1.2 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 12.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 1.0 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 1.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.2 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.2 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 5.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.7 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.2 | 2.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 1.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 1.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.7 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.2 | 0.9 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.2 | 1.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.7 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.5 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.2 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 1.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.2 | 7.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 3.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.2 | 0.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.7 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.2 | 24.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.9 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 4.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 2.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.8 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.2 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 2.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:0002590 | negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 1.9 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.6 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 1.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.2 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.2 | 0.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 8.1 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 2.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 2.0 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.6 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.2 | 0.6 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 0.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 3.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 1.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 4.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 1.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 4.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 0.6 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.2 | 13.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 1.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.6 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.2 | 1.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.2 | 0.6 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.2 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.5 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 1.0 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
0.2 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 10.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 2.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 1.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.4 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 0.4 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 3.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 7.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 4.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.3 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.7 | GO:0042245 | RNA repair(GO:0042245) |
0.2 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 3.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 9.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 1.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.7 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.2 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 2.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 2.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.7 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.2 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 1.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.3 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 3.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.2 | GO:2000771 | regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) |
0.2 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.8 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.8 | GO:1904645 | response to beta-amyloid(GO:1904645) |
0.2 | 2.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 4.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.6 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.2 | 2.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 2.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.2 | 5.2 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.2 | 2.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.2 | 1.6 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 1.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 2.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 0.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.2 | 1.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 1.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 1.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 4.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.6 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.2 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.2 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 1.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 2.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.2 | 1.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.1 | 2.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.1 | 0.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.1 | 0.6 | GO:0015793 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 2.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 23.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 1.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.4 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.7 | GO:1990743 | protein sialylation(GO:1990743) |
0.1 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 2.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.9 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.1 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.1 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.4 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
0.1 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 2.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.0 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.3 | GO:2000864 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.8 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.5 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 1.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.5 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.1 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 2.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.3 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 4.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 3.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 4.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 1.2 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 1.8 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.1 | 1.0 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:0000393 | generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0017126 | nucleologenesis(GO:0017126) |
0.1 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 1.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 1.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.4 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.1 | 0.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.4 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.1 | 0.5 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 1.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.6 | GO:1900150 | regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.1 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.9 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 1.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.1 | 0.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.8 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 1.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 4.8 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.3 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.1 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 1.3 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.1 | 1.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 7.8 | GO:0016072 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.1 | 0.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.4 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 1.9 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 1.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 1.3 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 1.3 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.3 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.9 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 2.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 2.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.4 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 2.1 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 2.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
0.1 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.3 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.4 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.7 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 1.0 | GO:0042401 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.1 | 0.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 2.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 3.1 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 1.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 1.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 2.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 2.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.2 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.1 | 0.7 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 3.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 2.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 1.3 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.1 | 1.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.9 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 1.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 1.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.2 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 1.3 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
0.1 | 0.6 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:1902477 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.3 | GO:0072023 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.2 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.2 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.1 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.1 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.1 | 2.7 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 1.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 3.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.2 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
0.1 | 0.2 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 2.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 1.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 1.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.2 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 2.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 1.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER(GO:2000156) |
0.0 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.2 | GO:0051198 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.8 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 1.0 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 1.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 1.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.3 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 1.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0046436 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.0 | 3.2 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 1.3 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 2.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.6 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 1.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 1.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 1.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 1.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.2 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.3 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 1.1 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 0.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:0070257 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 4.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 1.8 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.8 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:1903487 | regulation of lactation(GO:1903487) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 2.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 1.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 1.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.0 | 0.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.0 | 0.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.0 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 22.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.3 | 7.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 7.0 | GO:0031904 | endosome lumen(GO:0031904) |
2.3 | 9.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.9 | 9.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.9 | 7.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.5 | 8.9 | GO:0032437 | cuticular plate(GO:0032437) |
1.4 | 15.9 | GO:0042629 | mast cell granule(GO:0042629) |
1.4 | 4.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.4 | 5.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.1 | 3.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.1 | 3.3 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.1 | 3.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.1 | 6.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 5.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.0 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
1.0 | 10.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.9 | 4.6 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.9 | 9.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 5.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 2.6 | GO:0036398 | TCR signalosome(GO:0036398) |
0.9 | 6.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 2.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.9 | 5.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 2.5 | GO:1904511 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
0.8 | 3.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.8 | 3.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.8 | 2.4 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.8 | 5.5 | GO:0071914 | prominosome(GO:0071914) |
0.8 | 7.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.8 | 19.2 | GO:0042581 | specific granule(GO:0042581) |
0.7 | 3.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 2.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.7 | 4.9 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 6.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 10.7 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 2.0 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.7 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 1.9 | GO:0070985 | TFIIK complex(GO:0070985) |
0.6 | 3.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 2.5 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.6 | 1.8 | GO:1990031 | pinceau fiber(GO:1990031) |
0.6 | 9.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 1.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 7.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 1.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.6 | 9.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 2.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 5.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.6 | GO:0070992 | translation initiation complex(GO:0070992) |
0.5 | 6.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 1.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.5 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 2.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 3.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 2.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.5 | 1.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.5 | 3.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 3.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 8.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 0.5 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.5 | 36.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 1.8 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.4 | 6.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 5.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 0.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 14.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 2.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 1.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 5.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 0.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
0.4 | 12.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 2.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 0.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 2.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 11.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 1.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 3.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 1.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.4 | 2.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.4 | 5.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.4 | 3.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 1.8 | GO:0031251 | PAN complex(GO:0031251) |
0.4 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 4.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.9 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.3 | 5.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 3.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 11.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.3 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 1.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.3 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.0 | GO:0034455 | t-UTP complex(GO:0034455) |
0.3 | 1.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 0.9 | GO:1990879 | CST complex(GO:1990879) |
0.3 | 13.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 11.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 2.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 4.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 4.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 5.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 16.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 0.6 | GO:0071920 | cleavage body(GO:0071920) |
0.3 | 0.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 6.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 2.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 3.6 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 2.7 | GO:0030894 | DNA replication factor A complex(GO:0005662) replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.3 | 2.0 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 4.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 3.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 4.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.3 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 1.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.3 | 2.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 17.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 4.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 3.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 22.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 9.0 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.3 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 2.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.0 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.3 | 11.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 3.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 9.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 21.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 2.8 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 1.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 30.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 3.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 2.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 7.2 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 0.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 0.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 5.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 3.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 9.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 3.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 1.4 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 12.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 7.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.6 | GO:1990752 | microtubule minus-end(GO:0036449) microtubule end(GO:1990752) |
0.2 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 2.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.6 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.2 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 1.9 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 6.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 4.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.2 | 3.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.7 | GO:0008623 | CHRAC(GO:0008623) |
0.2 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 0.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 3.3 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 4.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 2.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 3.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 10.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 12.8 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.6 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 2.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 10.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 4.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.5 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 16.3 | GO:0005819 | spindle(GO:0005819) |
0.2 | 1.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 3.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 14.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 17.0 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 9.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 2.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 2.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.7 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 1.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 4.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 57.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 5.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 6.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 4.9 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 2.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 15.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.6 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.1 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0005607 | laminin-1 complex(GO:0005606) laminin-2 complex(GO:0005607) |
0.1 | 0.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 3.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.6 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 10.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 6.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 2.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 12.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 6.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 4.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 1.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 2.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.7 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 9.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 3.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 8.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 7.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0002095 | caveolar macromolecular signaling complex(GO:0002095) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 2.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 4.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 4.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 9.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 2.7 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0098687 | chromosomal region(GO:0098687) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.1 | GO:1990032 | parallel fiber(GO:1990032) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 3.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 4.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.7 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 8.0 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.5 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 1.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 24.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.9 | 7.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.3 | 13.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.1 | 12.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
3.1 | 9.2 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
2.7 | 13.4 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
2.6 | 18.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
2.6 | 15.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.5 | 25.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.4 | 11.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.2 | 24.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.1 | 8.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
2.1 | 12.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.7 | 5.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.6 | 6.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.6 | 4.7 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.5 | 4.6 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.4 | 4.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.3 | 6.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.3 | 5.1 | GO:0043532 | angiostatin binding(GO:0043532) |
1.2 | 11.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 3.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.1 | 3.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
1.1 | 4.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 9.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.0 | 9.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 2.9 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.0 | 2.9 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.9 | 8.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 11.1 | GO:0008061 | chitin binding(GO:0008061) |
0.9 | 2.7 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
0.9 | 2.7 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.9 | 3.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.9 | 7.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 3.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 5.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.8 | 2.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.8 | 4.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 4.2 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.8 | 3.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.8 | 2.4 | GO:0003896 | DNA primase activity(GO:0003896) |
0.8 | 6.4 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.8 | 3.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 5.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.8 | 3.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.8 | 2.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.8 | 6.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 4.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 5.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.7 | 2.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.7 | 6.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.7 | 2.9 | GO:0032093 | SAM domain binding(GO:0032093) |
0.7 | 2.9 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.7 | 4.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.7 | 1.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.6 | 4.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 1.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 1.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 3.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.6 | 1.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.6 | 4.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 2.3 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.6 | 1.7 | GO:0004349 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.6 | 1.7 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.6 | 0.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 1.7 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.5 | 1.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 1.6 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.5 | 5.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 4.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 5.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 6.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 2.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.5 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 11.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.5 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.5 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 5.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 3.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 1.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.5 | 1.5 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.5 | 2.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.0 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.5 | 4.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.5 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 2.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.5 | 1.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 4.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 3.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.5 | 1.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 3.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.5 | 0.5 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
0.5 | 5.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 1.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 12.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 22.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 4.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.3 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.4 | 1.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.3 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.4 | 13.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 2.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 1.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.4 | 2.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.4 | 2.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 2.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.4 | 0.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.4 | 1.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.4 | 2.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 2.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 10.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 4.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 1.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 4.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 3.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 2.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 0.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 1.2 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.4 | 3.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 3.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 5.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 6.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 2.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.4 | 4.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 9.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 11.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 6.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 1.1 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.4 | 1.1 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.1 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.4 | 1.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 1.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 10.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 2.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.4 | 3.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 1.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 4.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 2.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.0 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.3 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 6.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 1.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 3.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 4.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.3 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 12.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 2.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 0.9 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.3 | 4.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 8.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 2.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.8 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 0.9 | GO:0047223 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 11.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 3.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 7.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.3 | 0.9 | GO:0032394 | MHC class Ib receptor activity(GO:0032394) |
0.3 | 1.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.3 | 2.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.3 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 3.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 2.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 0.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 1.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 15.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.8 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
0.3 | 0.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 7.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 3.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 13.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 5.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 3.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 8.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 2.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 3.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 3.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.8 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.3 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.8 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.3 | 12.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 5.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 3.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 11.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 5.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 6.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 0.7 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 1.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 3.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 3.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 11.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 2.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.9 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 1.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 2.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 4.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 3.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 3.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 15.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 4.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.9 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.2 | 0.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 4.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 15.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.2 | GO:0070540 | stearic acid binding(GO:0070540) |
0.2 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 5.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.9 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 2.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 2.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 2.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 2.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 0.5 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.2 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 7.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.2 | 3.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 27.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 3.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 1.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 4.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 9.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 3.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 20.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 8.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 3.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 12.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 3.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 9.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.5 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.2 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 4.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 2.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 1.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 7.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 1.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 4.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 3.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 16.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 11.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 8.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 4.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 5.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 1.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 7.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 4.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 3.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.5 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 3.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 3.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.1 | 4.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.6 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 8.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 5.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 2.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 5.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.7 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 9.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 3.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.9 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 4.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 4.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.2 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.1 | 11.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 2.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
0.1 | 0.9 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 0.7 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 3.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 5.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 2.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 2.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 1.4 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.7 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.1 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 12.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.1 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 3.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 3.8 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.1 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 4.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.8 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 2.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.2 | GO:0004135 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.1 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 3.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.1 | GO:1902121 | lithocholic acid binding(GO:1902121) |
0.1 | 0.1 | GO:0003681 | bent DNA binding(GO:0003681) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.1 | 0.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 8.3 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 2.6 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 1.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 1.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 4.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 1.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0070976 | TIR domain binding(GO:0070976) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 41.4 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 2.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.0 | 0.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 2.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 3.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 8.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 1.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 1.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.0 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.0 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 4.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 9.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.0 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 38.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 10.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 28.4 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 28.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.5 | 17.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 47.8 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 4.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 9.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 5.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 5.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 9.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 18.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 6.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 6.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 4.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 8.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 31.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 3.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 13.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 4.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 7.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 10.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 4.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 9.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 14.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 5.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 5.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 0.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 5.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 11.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 5.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 14.6 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 11.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 12.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 3.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 33.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 8.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 3.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 5.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 4.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 5.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 7.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 5.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 5.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 6.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 7.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 4.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 12.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 5.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 4.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 36.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.9 | 6.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.9 | 11.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 10.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.8 | 12.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 4.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.7 | 14.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 9.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 15.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 6.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 14.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 15.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 8.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 7.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 12.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 56.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 62.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 9.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 28.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 10.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 2.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 1.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 10.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 10.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 15.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 16.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 8.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.4 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 6.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 9.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 30.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 4.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 3.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 6.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 4.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 7.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 15.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 5.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 5.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 14.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 2.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 11.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 2.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 18.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 4.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 4.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 4.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 7.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 3.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 5.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 7.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 11.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 2.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 5.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 6.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 6.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 13.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.8 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 3.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 23.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.7 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 3.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 3.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 2.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 3.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 0.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 11.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 6.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 8.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 8.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 7.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 15.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 5.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 12.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 4.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 2.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 3.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 4.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 7.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 10.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 2.0 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 10.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 7.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |